Literature DB >> 1717551

Effects of IL-7 and IL-2 on highly enriched CD56+ natural killer cells. A comparative study.

B Naume1, T Espevik.   

Abstract

IL-7 has been shown to induce low levels of lymphokine-activated killer cell (LAK) activity in bulk PBMC populations. We report here that immunomagnetically purified CD56+ cells from peripheral blood generated high LAK activity in response to IL-7. The LAK activity induced by IL-7 was comparable to, or slightly lower than, the LAK activity induced by IL-2. When analyzing cells from the same donor, no detectable LAK-generating effect of IL-7 was registered in the PBMC population, in contrast to a substantial effect in the CD56+ population. IL-2 induced 8- to 15-fold higher proliferative activity in CD56+ cells, relative to IL-7. At suboptimal concentrations of IL-2, IL-7 had a synergistic effect on the proliferation. IL-2-neutralizing antibodies did not abrogate the IL-7-induced proliferation or LAK generation. Both IL-7 and IL-2 induced comparable levels of 75-kDa TNFR expression, whereas IL-2R alpha expression was higher in IL-7-stimulated CD56+ cells. Low levels of TNF were produced in response to IL-7 at day 5, as opposed to a 50-fold higher TNF production in response to IL-2. No IL-2 or IL-6 production was detected. Our data indicate that IL-7 has profound and direct effects on CD56+ cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717551

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer.

Authors:  Asa Andersson; Minu K Srivastava; Marni Harris-White; Min Huang; Li Zhu; David Elashoff; Robert M Strieter; Steven M Dubinett; Sherven Sharma
Journal:  Clin Cancer Res       Date:  2011-06-01       Impact factor: 12.531

2.  Arsenic trioxide enhances the cytotoxic effect of thalidomide in a KG-1a human acute mylogenous leukemia cell line.

Authors:  Erian Girgis; John Mahoney; Selina Darling-Reed; Magdi Soliman
Journal:  Oncol Lett       Date:  2010-05       Impact factor: 2.967

3.  HL-60 myeloid leukaemia cells acquire immunostimulatory capability upon treatment with retinoic acid: analysis of the responding population and mechanism of cytotoxic lymphocyte activation.

Authors:  S M Geary; L K Ashman
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

4.  Frequent expression of IL-7 gene transcripts in tumor cells of classical Hodgkin's disease.

Authors:  H D Foss; M Hummel; S Gottstein; K Ziemann; B Falini; H Herbst; H Stein
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

5.  Expression and function of alpha 4/beta 7 integrin on human natural killer cells.

Authors:  J J Pérez-Villar; J M Zapata; I Melero; A Postigo; E Sánchez-Madrid; M López-Botet
Journal:  Immunology       Date:  1996-09       Impact factor: 7.397

6.  Stimulation of B-cell lymphopoiesis by interleukin-7 leads to aggravation of murine leishmaniasis.

Authors:  A Gessner; A Will; M Vieth; K Schröppel; M Röllinghoff
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

7.  Interleukin-7 enhances antimicrobial activity against Leishmania major in murine macrophages.

Authors:  A Gessner; M Vieth; A Will; K Schröppel; M Röllinghoff
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  Natural killer (NK) cell activity during HIV infection: a decrease in NK activity is observed at the clonal level and is not restored after in vitro long-term culture of NK cells.

Authors:  D Scott-Algara; F Vuillier; A Cayota; G Dighiero
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

9.  Interleukin-7 is a potent co-stimulus of the adhesion pathway involving CD2 and CD28 molecules.

Authors:  R Costello; H Brailly; F Mallet; C Mawas; D Olive
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

10.  On the mode of action of intravesical bacillus Calmette-Guérin: in vitro characterization of BCG-activated killer cells.

Authors:  A Böhle; A Thanhäuser; A J Ulmer; T Mattern; M Ernst; H D Flad; D Jocham
Journal:  Urol Res       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.